A Study to Evaluate INCA033989 Administered as a Monotherapy or in Combination With Ruxolitinib in Participants With Myeloproliferative Neoplasms
Incyte Corporation
Incyte Corporation
Incyte Corporation
National Cancer Institute (NCI)
Incyte Corporation
Merck Sharp & Dohme LLC
University of Southern California
Incyte Corporation
University Hospital, Brest
University of Washington
University of California, Irvine
University Hospital, Angers
Massachusetts General Hospital
Icahn School of Medicine at Mount Sinai
University Hospital, Angers
Thomas Jefferson University
Hangzhou GluBio Pharmaceutical Co., Ltd.
Barbara Ann Karmanos Cancer Institute
Icahn School of Medicine at Mount Sinai
Tongji Hospital
Fox Chase Cancer Center